A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam [version 1; peer review: 1 approved, 2 approved with reservations]

A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam [version 1; peer review: 1 approved, 2 approved with reservations]

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

Full description

Bibliographic Details
Main Authors: Evelyne Kestelyn, Nguyen Thi Phuong Dung, Yen Lam Minh, Le Manh Hung, Nguyen Minh Quan, Nguyen Thanh Dung, Ngo Ngoc Quang Minh, Tran Chanh Xuan, Nguyen Thanh Phong, Van Ninh Thi Thanh, Joseph Donovan, Tran Nguyen Hoang Tu, Le Thanh Hoang Nhat, Nguyen Thanh Truong, Dinh Nguyen Huy Man, Huynh Phuong Thao, Nghiêm My Ngoc, Vo Thanh Lam, Huynh Hong Phat, Phan Minh Phuong, Ronald B. Geskus, Vo Thi Nhi Ha, Nguyen Ngo Quang, Hien Tran Tinh, Le Van Tan, Guy E. Thwaites, Jeremy N. Day, Nguyen Van Vinh Chau, OUCRU COVID-19 Research Group
Format: Article
Language:English
Published: Wellcome 2020-06-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/5-141/v1

Internet

https://wellcomeopenresearch.org/articles/5-141/v1

Similar Items